Discover 602 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Omaha hosts numerous active clinical trials targeting diseases such as cancer, asthma, and autoimmune disorders like lupus. The city’s leading research institutions are recruiting participants, both as a healthy volunteer and those looking for studies related to specific health conditions, offering opportunities to take part in groundbreaking research and access innovative treatments.
Filter
2
Filter results
Results: 602
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Omaha NE, Lincoln NE, Des Moines IA, Sioux Falls SD,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Omaha NE, Sioux Falls SD, Kansas City MO, Iowa City IA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase2, Recruiting
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
for
Chronic Graft-versus-Host-Disease,
Location: Omaha NE, Saint Louis MO, Toronto, Portland OR
Sponsor: University of British Columbia
Sex: All
Age: 18+
Code: NCT05692713
Recruiting
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
for
Parkinson's Disease, Sleep Fragmentation
Location: Omaha NE, Philadelphia PA
Sponsor: University of Nebraska
Sex: All
Age: 18 - 70+
Code: NCT05070013
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Omaha NE, Kansas City MO, Prairie Village KS,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma